(BUSINESS WIRE)--Ricerca is the only North American CRO that takes pharmaceutical and biotech companies straight through from IP to IND. Our state-of-the-art facility combined with over 300 scientists and support staff provides all of the discovery and development services required to bring target or drug candidates to complete IND submission. Ricerca’s unique ability to seamlessly integrate chemistry and biology, along with report writing and regulatory services at one location, allows companies to achieve their preclinical destination—faster and without any detours.
